 | • レポートコード：MRC2Q12-19383 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、放射性医薬品療法のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 放射性医薬品療法のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 放射性医薬品療法の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 放射性医薬品療法のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの放射性医薬品療法の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の放射性医薬品療法の売上および2028年までの予測に焦点を当てています。 放射性医薬品療法のグローバル主要企業には、Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navideaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 放射性医薬品療法市場は、タイプとアプリケーションによって区分されます。世界の放射性医薬品療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他 【アプリケーション別セグメント】 腫瘍学、循環器内科、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 放射性医薬品療法製品概要 - タイプ別市場（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他） - アプリケーション別市場（腫瘍学、循環器内科、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の放射性医薬品療法販売量予測2017-2028 - 世界の放射性医薬品療法売上予測2017-2028 - 放射性医薬品療法の地域別販売量 - 放射性医薬品療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別放射性医薬品療法販売量 - 主要メーカー別放射性医薬品療法売上 - 主要メーカー別放射性医薬品療法価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（アクチニウム-225、ルテチウム-177、ラジウム-223、ホルミウム-166、その他） - 放射性医薬品療法のタイプ別販売量 - 放射性医薬品療法のタイプ別売上 - 放射性医薬品療法のタイプ別価格 ・アプリケーション別市場規模（腫瘍学、循環器内科、その他） - 放射性医薬品療法のアプリケーション別販売量 - 放射性医薬品療法のアプリケーション別売上 - 放射性医薬品療法のアプリケーション別価格 ・北米市場 - 北米の放射性医薬品療法市場規模（タイプ別、アプリケーション別） - 主要国別の放射性医薬品療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの放射性医薬品療法市場規模（タイプ別、アプリケーション別） - 主要国別の放射性医薬品療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の放射性医薬品療法市場規模（タイプ別、アプリケーション別） - 主要国別の放射性医薬品療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の放射性医薬品療法市場規模（タイプ別、アプリケーション別） - 主要国別の放射性医薬品療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの放射性医薬品療法市場規模（タイプ別、アプリケーション別） - 主要国別の放射性医薬品療法市場規模（トルコ、サウジアラビア） ・企業情報 Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea ・産業チェーン及び販売チャネル分析 - 放射性医薬品療法の産業チェーン分析 - 放射性医薬品療法の原材料 - 放射性医薬品療法の生産プロセス - 放射性医薬品療法の販売及びマーケティング - 放射性医薬品療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 放射性医薬品療法の産業動向 - 放射性医薬品療法のマーケットドライバー - 放射性医薬品療法の課題 - 放射性医薬品療法の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Radiopharmaceutical Therapy estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Radiopharmaceutical Therapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Radiopharmaceutical Therapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Radiopharmaceutical Therapy is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Radiopharmaceutical Therapy include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Radiopharmaceutical Therapy companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Radiopharmaceutical Therapy market. Further, it explains the major drivers and regional dynamics of the global Radiopharmaceutical Therapy market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Radiopharmaceutical Therapy Segment by Type
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Radiopharmaceutical Therapy Segment by Application
Oncology
Cardiology
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Radiopharmaceutical Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Radiopharmaceutical Therapy market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Radiopharmaceutical Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Radiopharmaceutical Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Radiopharmaceutical Therapy revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Radiopharmaceutical Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Radiopharmaceutical Therapy revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Radiopharmaceutical Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiopharmaceutical Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiopharmaceutical Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiopharmaceutical Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Radiopharmaceutical Therapy Market Perspective (2017-2028)
2.2 Radiopharmaceutical Therapy Growth Trends by Region
2.2.1 Radiopharmaceutical Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Radiopharmaceutical Therapy Historic Market Size by Region (2017-2022)
2.2.3 Radiopharmaceutical Therapy Forecasted Market Size by Region (2023-2028)
2.3 Radiopharmaceutical Therapy Market Dynamics
2.3.1 Radiopharmaceutical Therapy Industry Trends
2.3.2 Radiopharmaceutical Therapy Market Drivers
2.3.3 Radiopharmaceutical Therapy Market Challenges
2.3.4 Radiopharmaceutical Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiopharmaceutical Therapy Players by Revenue
3.1.1 Global Top Radiopharmaceutical Therapy Players by Revenue (2017-2022)
3.1.2 Global Radiopharmaceutical Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiopharmaceutical Therapy Revenue
3.4 Global Radiopharmaceutical Therapy Market Concentration Ratio
3.4.1 Global Radiopharmaceutical Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiopharmaceutical Therapy Revenue in 2021
3.5 Radiopharmaceutical Therapy Key Players Head office and Area Served
3.6 Key Players Radiopharmaceutical Therapy Product Solution and Service
3.7 Date of Enter into Radiopharmaceutical Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiopharmaceutical Therapy Breakdown Data by Type
4.1 Global Radiopharmaceutical Therapy Historic Market Size by Type (2017-2022)
4.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Type (2023-2028)
5 Radiopharmaceutical Therapy Breakdown Data by Application
5.1 Global Radiopharmaceutical Therapy Historic Market Size by Application (2017-2022)
5.2 Global Radiopharmaceutical Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Radiopharmaceutical Therapy Market Size (2017-2028)
6.2 North America Radiopharmaceutical Therapy Market Size by Type
6.2.1 North America Radiopharmaceutical Therapy Market Size by Type (2017-2022)
6.2.2 North America Radiopharmaceutical Therapy Market Size by Type (2023-2028)
6.2.3 North America Radiopharmaceutical Therapy Market Share by Type (2017-2028)
6.3 North America Radiopharmaceutical Therapy Market Size by Application
6.3.1 North America Radiopharmaceutical Therapy Market Size by Application (2017-2022)
6.3.2 North America Radiopharmaceutical Therapy Market Size by Application (2023-2028)
6.3.3 North America Radiopharmaceutical Therapy Market Share by Application (2017-2028)
6.4 North America Radiopharmaceutical Therapy Market Size by Country
6.4.1 North America Radiopharmaceutical Therapy Market Size by Country (2017-2022)
6.4.2 North America Radiopharmaceutical Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Radiopharmaceutical Therapy Market Size (2017-2028)
7.2 Europe Radiopharmaceutical Therapy Market Size by Type
7.2.1 Europe Radiopharmaceutical Therapy Market Size by Type (2017-2022)
7.2.2 Europe Radiopharmaceutical Therapy Market Size by Type (2023-2028)
7.2.3 Europe Radiopharmaceutical Therapy Market Share by Type (2017-2028)
7.3 Europe Radiopharmaceutical Therapy Market Size by Application
7.3.1 Europe Radiopharmaceutical Therapy Market Size by Application (2017-2022)
7.3.2 Europe Radiopharmaceutical Therapy Market Size by Application (2023-2028)
7.3.3 Europe Radiopharmaceutical Therapy Market Share by Application (2017-2028)
7.4 Europe Radiopharmaceutical Therapy Market Size by Country
7.4.1 Europe Radiopharmaceutical Therapy Market Size by Country (2017-2022)
7.4.2 Europe Radiopharmaceutical Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiopharmaceutical Therapy Market Size (2017-2028)
8.2 Asia-Pacific Radiopharmaceutical Therapy Market Size by Type
8.2.1 Asia-Pacific Radiopharmaceutical Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Radiopharmaceutical Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Radiopharmaceutical Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Radiopharmaceutical Therapy Market Size by Application
8.3.1 Asia-Pacific Radiopharmaceutical Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Radiopharmaceutical Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Radiopharmaceutical Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region
8.4.1 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Radiopharmaceutical Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Radiopharmaceutical Therapy Market Size (2017-2028)
9.2 Latin America Radiopharmaceutical Therapy Market Size by Type
9.2.1 Latin America Radiopharmaceutical Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Radiopharmaceutical Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Radiopharmaceutical Therapy Market Share by Type (2017-2028)
9.3 Latin America Radiopharmaceutical Therapy Market Size by Application
9.3.1 Latin America Radiopharmaceutical Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Radiopharmaceutical Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Radiopharmaceutical Therapy Market Share by Application (2017-2028)
9.4 Latin America Radiopharmaceutical Therapy Market Size by Country
9.4.1 Latin America Radiopharmaceutical Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Radiopharmaceutical Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiopharmaceutical Therapy Market Size (2017-2028)
10.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Type
10.2.1 Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Radiopharmaceutical Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Radiopharmaceutical Therapy Market Size by Application
10.3.1 Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Radiopharmaceutical Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country
10.4.1 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Radiopharmaceutical Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Bracco Imaging Business Overview
11.1.3 Bracco Imaging Radiopharmaceutical Therapy Introduction
11.1.4 Bracco Imaging Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.1.5 Bracco Imaging Recent Developments
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Radiopharmaceutical Therapy Introduction
11.2.4 Bayer Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.2.5 Bayer Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Radiopharmaceutical Therapy Introduction
11.3.4 Mallinckrodt Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.3.5 Mallinckrodt Recent Developments
11.4 Nordion
11.4.1 Nordion Company Details
11.4.2 Nordion Business Overview
11.4.3 Nordion Radiopharmaceutical Therapy Introduction
11.4.4 Nordion Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.4.5 Nordion Recent Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Triad Isotopes Business Overview
11.5.3 Triad Isotopes Radiopharmaceutical Therapy Introduction
11.5.4 Triad Isotopes Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.5.5 Triad Isotopes Recent Developments
11.6 Lantheus
11.6.1 Lantheus Company Details
11.6.2 Lantheus Business Overview
11.6.3 Lantheus Radiopharmaceutical Therapy Introduction
11.6.4 Lantheus Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.6.5 Lantheus Recent Developments
11.7 IBA Group
11.7.1 IBA Group Company Details
11.7.2 IBA Group Business Overview
11.7.3 IBA Group Radiopharmaceutical Therapy Introduction
11.7.4 IBA Group Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.7.5 IBA Group Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Radiopharmaceutical Therapy Introduction
11.8.4 GE Healthcare Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.8.5 GE Healthcare Recent Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Details
11.9.2 China Isotope & Radiation Business Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Therapy Introduction
11.9.4 China Isotope & Radiation Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.9.5 China Isotope & Radiation Recent Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Details
11.10.2 Jubilant Pharma Business Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Therapy Introduction
11.10.4 Jubilant Pharma Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.10.5 Jubilant Pharma Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Radiopharmaceutical Therapy Introduction
11.11.4 Eli Lilly Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.11.5 Eli Lilly Recent Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Company Details
11.12.2 Advanced Accelerator Applications Business Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Introduction
11.12.4 Advanced Accelerator Applications Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.12.5 Advanced Accelerator Applications Recent Developments
11.13 SIEMENS
11.13.1 SIEMENS Company Details
11.13.2 SIEMENS Business Overview
11.13.3 SIEMENS Radiopharmaceutical Therapy Introduction
11.13.4 SIEMENS Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.13.5 SIEMENS Recent Developments
11.14 Dongcheng
11.14.1 Dongcheng Company Details
11.14.2 Dongcheng Business Overview
11.14.3 Dongcheng Radiopharmaceutical Therapy Introduction
11.14.4 Dongcheng Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.14.5 Dongcheng Recent Developments
11.15 Navidea
11.15.1 Navidea Company Details
11.15.2 Navidea Business Overview
11.15.3 Navidea Radiopharmaceutical Therapy Introduction
11.15.4 Navidea Revenue in Radiopharmaceutical Therapy Business (2017-2022)
11.15.5 Navidea Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer